These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30797663)

  • 1. Oral administration of Domain-I of beta-2glycoprotein-I induces immunological tolerance in experimental murine antiphospholipid syndrome.
    Shemer A; Willis R; Gonzalez EB; Romay-Penabad Z; Shovman O; Shoenfeld Y; Blank M; Amital H
    J Autoimmun; 2019 May; 99():98-103. PubMed ID: 30797663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerogenic dendritic cells specific for β2-glycoprotein-I Domain-I, attenuate experimental antiphospholipid syndrome.
    Zandman-Goddard G; Pierangeli SS; Gertel S; Blank M
    J Autoimmun; 2014 Nov; 54():72-80. PubMed ID: 24972993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral tolerance to low dose beta 2-glycoprotein I: immunomodulation of experimental antiphospholipid syndrome.
    Blank M; George J; Barak V; Tincani A; Koike T; Shoenfeld Y
    J Immunol; 1998 Nov; 161(10):5303-12. PubMed ID: 9820503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crassolide Suppresses Dendritic Cell Maturation and Attenuates Experimental Antiphospholipid Syndrome.
    Lin CC; Chang YK; Lin SC; Su JH; Chao YH; Tang KT
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33923336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of TLR4 on B Cell Activation and Anti-
    Cheng S; Wang H; Zhou H
    J Immunol Res; 2016; 2016():1719720. PubMed ID: 27868072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β2-Glycoprotein-I based peptide regulate endothelial-cells tissue-factor expression via negative regulation of pGSK3β expression and reduces experimental-antiphospholipid-syndrome.
    Blank M; Baraam L; Eisenstein M; Fridkin M; Dardik R; Heldman Y; Katchalski-Katzir E; Shoenfeld Y
    J Autoimmun; 2011 Aug; 37(1):8-17. PubMed ID: 21524885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR4 is involved in the pathogenic effects observed in a murine model of antiphospholipid syndrome.
    Xie H; Kong X; Zhou H; Xie Y; Sheng L; Wang T; Xia L; Yan J
    Clin Immunol; 2015 Oct; 160(2):198-210. PubMed ID: 26065621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerogenic dendritic cells inhibit antiphospholipid syndrome derived effector/memory CD4⁺ T cell response to β2GPI.
    Torres-Aguilar H; Blank M; Kivity S; Misgav M; Luboshitz J; Pierangeli SS; Shoenfeld Y
    Ann Rheum Dis; 2012 Jan; 71(1):120-8. PubMed ID: 21914629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotic supplementation with Lactobacillus casei (Actimel) induces a Th1 response in an animal model of antiphospholipid syndrome.
    Amital H; Gilburd B; Shoenfeld Y
    Ann N Y Acad Sci; 2007 Sep; 1110():661-9. PubMed ID: 17911481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome.
    Blank M; Krause I; Fridkin M; Keller N; Kopolovic J; Goldberg I; Tobar A; Shoenfeld Y
    J Clin Invest; 2002 Mar; 109(6):797-804. PubMed ID: 11901188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of Toll-like receptor 4 on β2-glycoprotein I-induced B cell activation in mouse model.
    Cheng S; He C; Zhou H; Kong X; Xie H; Xia L; Yan J
    Mol Immunol; 2016 Mar; 71():78-86. PubMed ID: 26872007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice.
    Ostertag MV; Liu X; Henderson V; Pierangeli SS
    Lupus; 2006; 15(6):358-65. PubMed ID: 16830882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome.
    Chighizola CB; Pregnolato F; Andreoli L; Bodio C; Cesana L; Comerio C; Gerosa M; Grossi C; Kumar R; Lazzaroni MG; Mahler M; Mattia E; Nalli C; Norman GL; Raimondo MG; Ruffatti A; Tonello M; Trespidi L; Tincani A; Borghi MO; Meroni PL
    J Autoimmun; 2018 Jun; 90():76-83. PubMed ID: 29454510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid syndrome: 30 years and our contribution.
    Koike T
    Int J Rheum Dis; 2015 Feb; 18(2):233-41. PubMed ID: 25524556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of thrombotic properties of persistent autoimmune anti-β2GPI antibodies in the mouse model of antiphospholipid syndrome.
    Kolyada A; Porter A; Beglova N
    Blood; 2014 Feb; 123(7):1090-7. PubMed ID: 24277078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoreactive CD4(+) T-cell clones to beta2-glycoprotein I in patients with antiphospholipid syndrome: preferential recognition of the major phospholipid-binding site.
    Arai T; Yoshida K; Kaburaki J; Inoko H; Ikeda Y; Kawakami Y; Kuwana M
    Blood; 2001 Sep; 98(6):1889-96. PubMed ID: 11535526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies.
    Metzger J; von Landenberg P; Kehrel M; Buhl A; Lackner KJ; Luppa PB
    Clin Chem; 2007 Jun; 53(6):1137-43. PubMed ID: 17434906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome.
    Blank M; Krause I; Magrini L; Spina G; Kalil J; Jacobsen S; Thiesen HJ; Cunningham MW; Guilherme L; Shoenfeld Y
    Rheumatology (Oxford); 2006 Jul; 45(7):833-41. PubMed ID: 16705050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An A1-A1 mutant with improved binding and inhibition of β2GPI/antibody complexes in antiphospholipid syndrome.
    Kolyada A; Karageorgos I; Mahlawat P; Beglova N
    FEBS J; 2015 Mar; 282(5):864-73. PubMed ID: 25546421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-chain fatty acid oxidation changes in a β2 glycoprotein I-induced preeclampsia-like mouse model.
    Ding X; Yang Z; Han Y; Yu H
    Placenta; 2014 Jun; 35(6):392-7. PubMed ID: 24713206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.